☆ 4.3 Article

Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion

JOURNAL OF PSYCHOPHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Neurosciences

The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression

Muhammad Youshay Jawad et al.

Summary: Ketamine has emerged as a novel and effective antidepressant, with the potential to improve various domains of depressive symptomatology. While its effectiveness in reducing depression severity is well-studied, more research is needed to explore its effects on cognition, anhedonia, suicidality, and psychosocial functionality. Findings suggest that ketamine is most effective in reducing suicidality but further studies are required to assess its effectiveness in other domains.

NEUROPHARMACOLOGY (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Long-term safety of ketamine and esketamine in treatment of depression

Sina Nikayin et al.

Summary: Ketamine and esketamine have generally transient, mild, and self-limited side effects. The use of esketamine could increase the risk of lower urinary tract symptoms, but severe bladder pathology has not been reported at recommended doses. High doses of ketamine may lead to long-term impairments in cognition, but esketamine clinical trials suggest that cognition remains stable or improves over time when used appropriately.

EXPERT OPINION ON DRUG SAFETY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression

Mu-Hong Chen et al.

Summary: Pretreatment working memory function may predict the treatment response to low-dose ketamine infusion in patients with treatment-resistant depression. Patients with poorer working memory function at baseline may show a better response to ketamine infusion.

PHARMACOPSYCHIATRY (2022)

添加到收藏夹

Article Psychiatry

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation

Yanling Zhou et al.

Summary: This study demonstrates that ketamine treatment can improve suicidal ideation, and this improvement is partially mediated by the enhancement of cognitive function.

FRONTIERS IN PSYCHIATRY (2022)

添加到收藏夹

Review Psychiatry

The abuse liability of ketamine: A scoping review of preclinical and clinical studies

Tuyen T. Le et al.

Summary: This scoping review examines the abuse liability of ketamine and its enantiomers. Preclinical studies suggest that (R,S)-ketamine and (S)-ketamine have a higher risk for abuse, while (R)-ketamine shows minimal abuse liability at doses relevant for antidepressant effects. Limited clinical studies indicate that ketamine administration in professionally controlled settings did not result in misuse, dependence, diversion, or gateway activity in patients with treatment-resistant depression (TRD).

JOURNAL OF PSYCHIATRIC RESEARCH (2022)

添加到收藏夹

Article Psychiatry

Cognitive flexibility and suicide risk indicators among psychiatric inpatients

Laura A. Novak et al.

Summary: In patients at risk for suicide, cognitive flexibility was found to be associated with lower depressive symptoms and worst point suicide ideation in the past month, but was not predictive of lower levels of hopelessness.

PSYCHIATRY RESEARCH (2022)

添加到收藏夹

Review Psychiatry

Efficacy of psychotropic medications on suicide and self-injury: a meta-analysis of randomized controlled trials

Xieyining Huang et al.

Summary: Psychotropic medications have a small treatment effect on self-injurious thoughts and behaviors, but further research is needed to understand the treatment mechanisms and causal processes.

TRANSLATIONAL PSYCHIATRY (2022)

添加到收藏夹

Article Clinical Neurology

Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients

Xiaoyu Chen et al.

Summary: The study found that in MDD patients, ketamine treatment significantly improved working memory, and this improvement was associated with alleviation of depressive symptoms and reduction in suicidal ideation. Furthermore, the improvement in working memory may predict the anti-suicidal ideation response of ketamine.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

添加到收藏夹

Article Clinical Neurology

Neurocognitive functioning predicts suicidal behaviour in young people with affective disorders

Catherine M. McHugh et al.

Summary: The study found that better neurocognitive functioning predicts suicidal behavior during care in young people with affective disorders, contrary to expectations. While other populations with suicidal behavior often experience neurocognitive deficits, this does not appear to be the case for young people with affective disorders.

JOURNAL OF AFFECTIVE DISORDERS (2021)

添加到收藏夹

Review Psychiatry

The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis

Jiaqi Xiong et al.

Summary: The study aimed to evaluate the acute anti-suicidal ideation effects of single-dose ketamine in different formulations and routes of administration by pooling the results from randomized controlled trials. The findings suggest that intravenous ketamine and intranasal esketamine are associated with robust reductions in suicidal thoughts at 2-h, 4-h, and 24-h post-intervention. Further research on intramuscular, oral, and sublingual ketamine, as well as comparative studies, are needed to evaluate the efficacy of these formulations and routes of administration in reducing suicidal ideation.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

添加到收藏夹

Review Psychiatry

Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review

Ashley N. Siegel et al.

Summary: This review evaluated the effects of intranasal esketamine and intravenous ketamine on patients with suicidal ideation. Results indicate that ketamine may rapidly reduce suicidal ideation and depressive symptoms, with potential short-lasting effects. The treatment was deemed relatively safe in the short term, and future clinical trials are encouraged to include this study population.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

添加到收藏夹

Article Psychology, Clinical

Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation

John G. Keilp et al.

Summary: The study demonstrates that ketamine has a positive therapeutic effect on suicidal behavior in depressed patients, rapidly improving suicidal ideation and mood while enhancing neurocognitive functioning, specifically in reaction time and interference processing/cognitive control. These results suggest additional independent therapeutic effects for ketamine in treating depressed patients at risk for suicidal behavior.

JOURNAL OF CLINICAL PSYCHIATRY (2021)

添加到收藏夹

Article Psychiatry

Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial

Samuel T. Wilkinson et al.

Summary: This study aimed to investigate the feasibility and efficacy of CBT in maintaining the antidepressant effects of ketamine in TRD patients. The results showed that the CBT group had sustained improvement at the 14-week follow-up, and responders in the emotional N-back testing demonstrated cognitive improvement.

PSYCHOTHERAPY AND PSYCHOSOMATICS (2021)

添加到收藏夹

Review Psychiatry

Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials

Katrina Witt et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)

添加到收藏夹

Article Psychiatry

Towards the objective assessment of suicidal states: Some neurocognitive deficits may be temporally related to suicide attempt

Alejandro Interian et al.

PSYCHIATRY RESEARCH (2020)

添加到收藏夹

Article Psychiatry

Neurocognitive vulnerability to youth suicidal behavior

Donna Ruch et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2020)

添加到收藏夹

Article Psychiatry

Longitudinal suicide ideation trajectories in a clinical trial of brief CBT for US military personnel recently discharged from psychiatric hospitalization

Daniel J. Lee et al.

PSYCHIATRY RESEARCH (2020)

添加到收藏夹

Review Clinical Neurology

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

Roger S. McIntyre et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

添加到收藏夹

Article Clinical Neurology

Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)

Mu-Hong Chen et al.

JOURNAL OF AFFECTIVE DISORDERS (2019)

添加到收藏夹

Article Psychiatry

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

Samuel T. Wilkinson et al.

AMERICAN JOURNAL OF PSYCHIATRY (2018)

添加到收藏夹

Article Neurosciences

Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression

Tung-Ping Su et al.

NEUROPSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Letter Psychiatry

Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment

Melvyn Weibin Zhang et al.

AMERICAN JOURNAL OF PSYCHIATRY (2016)

添加到收藏夹

Article Ethics

Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications

Melvyn W. Zhang et al.

BMC MEDICAL ETHICS (2016)

添加到收藏夹

Article Neurosciences

The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study

Cheng-Ta Li et al.

HUMAN BRAIN MAPPING (2016)

添加到收藏夹

Article Pharmacology & Pharmacy

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment A Procognitive Effect

Yena Lee et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Editorial Material Psychiatry

Controversies of the Effect of Ketamine on Cognition

Melvyn W. B. Zhang et al.

FRONTIERS IN PSYCHIATRY (2016)

添加到收藏夹

Article Psychiatry

How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study Enrollment

Sheldon H. Preskorn et al.

JOURNAL OF PSYCHIATRIC PRACTICE (2015)

添加到收藏夹

Editorial Material Medicine, General & Internal

MEDICINE AND THE MEDIA Ketamine's potential as a rapid antidepressant was overplayed

Melvyn W. B. Zhang et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Editorial Material Medicine, General & Internal

MEDICINE AND THE MEDIA Ketamine's potential as a rapid antidepressant was overplayed

Melvyn W. B. Zhang et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Psychology, Clinical

EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION

Rebecca B. Price et al.

DEPRESSION AND ANXIETY (2014)

添加到收藏夹

Article Psychology, Clinical

Neuropsychological function and suicidal behavior: attention control, memory and executive dysfunction in suicide attempt

J. G. Keilp et al.

PSYCHOLOGICAL MEDICINE (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.